Touchstone International Medical Science Co., Ltd. (SHA:688013)

SHA:688013 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	277.96	272.34	253.6	231.73	213.74	163.34
Other Revenue	0.03	0.03	0.04	0.31	0	0
Revenue	277.99	272.37	253.65	232.03	213.74	163.34
Revenue Growth (YoY)	9.28%	7.38%	9.31%	8.56%	30.85%	-5.45%
Cost of Revenue	116.02	113.64	111.8	99.8	91.27	68.25
Gross Profit	161.97	158.73	141.85	132.23	122.47	95.09
Selling, General & Admin	77.67	74.66	71.9	61.66	62.37	48.47
Research & Development	37.66	35.99	35.32	34.75	29.28	15.37
Other Operating Expenses	1.97	1.65	4.67	2.39	2.13	1.35
Operating Expenses	117.82	112.24	112.2	98.97	94.05	65.27
Operating Income	44.15	46.49	29.65	33.27	28.41	29.82
Interest Expense	-0.24	-0.23	-0.09	-0.16	-	-
Interest & Investment Income	8.16	9.12	8.03	4.76	11.15	2.26
Currency Exchange Gain (Loss)	-0.01	-0.01	2.47	3.94	4	1.8
Other Non Operating Income (Expenses)	3.22	-0.17	1.89	-0.12	-0.06	-0.09
EBT Excluding Unusual Items	55.28	55.21	41.96	41.69	43.51	33.79
Gain (Loss) on Sale of Investments	-0.03	-1.89	4.06	2.09	0.44	0.56
Gain (Loss) on Sale of Assets	-0	-0	0	0.02	0.52	-0
Asset Writedown	-0.09	-	-	-	-	-
Legal Settlements	-	-	-	-	-1.08	-
Other Unusual Items	1.86	1.52	1.93	2.28	2.71	5.85
Pretax Income	57.03	54.83	47.95	46.08	46.09	40.2
Income Tax Expense	3.3	2.94	0.64	2.89	4.67	5.25
Net Income	53.73	51.89	47.31	43.2	41.42	34.95
Net Income to Common	53.73	51.89	47.31	43.2	41.42	34.95
Net Income Growth	14.41%	9.69%	9.53%	4.29%	18.52%	-16.80%
Shares Outstanding (Basic)	79	80	79	80	80	65
Shares Outstanding (Diluted)	81	81	82	82	81	65
Shares Change (YoY)	0.58%	-0.60%	0.09%	0.35%	25.49%	7.85%
EPS (Basic)	0.68	0.65	0.60	0.54	0.52	0.54
EPS (Diluted)	0.66	0.64	0.58	0.53	0.51	0.54
EPS Growth	13.75%	10.35%	9.43%	3.92%	-5.56%	-22.86%
Free Cash Flow	5.82	11.47	64.54	2.73	51.77	34.79
Free Cash Flow Per Share	0.07	0.14	0.79	0.03	0.64	0.54
Dividend Per Share	1.000	1.000	-	0.250	0.200	0.200
Dividend Growth	-	-	-	25.00%	-	-
Gross Margin	58.26%	58.28%	55.92%	56.99%	57.30%	58.22%
Operating Margin	15.88%	17.07%	11.69%	14.34%	13.29%	18.25%
Profit Margin	19.33%	19.05%	18.65%	18.62%	19.38%	21.39%
Free Cash Flow Margin	2.09%	4.21%	25.44%	1.18%	24.22%	21.30%
EBITDA	53.37	55.68	38.7	41.35	35.64	36.36
EBITDA Margin	19.20%	20.44%	15.26%	17.82%	16.67%	22.26%
D&A For EBITDA	9.22	9.19	9.05	8.09	7.22	6.54
EBIT	44.15	46.49	29.65	33.27	28.41	29.82
EBIT Margin	15.88%	17.07%	11.69%	14.34%	13.29%	18.25%
Effective Tax Rate	5.79%	5.36%	1.33%	6.27%	10.14%	13.07%
Revenue as Reported	277.99	272.37	253.65	232.03	213.74	163.34

Source: S&P Global Market Intelligence. Standard template. Financial Sources.